...
首页> 外文期刊>Indian journal of dermatology >Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients
【24h】

Peroxisome proliferator-activated receptor-γ gene polymorphism in psoriasis and its relation to obesity, metabolic syndrome, and narrowband ultraviolet B response: A case–control study in Egyptian patients

机译:银屑病中过氧化物酶体增殖物激活的受体-γ基因多态性及其与肥胖,代谢综合征和窄带紫外线B反应的关系:埃及患者的病例对照研究

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Psoriasis is a common dermatologic disease with multifactorial etiology in which genetic factors play a major role. Peroxisome proliferator-activated receptor (PPAR)-γ is expressed in keratinocytes and is known to affect cell maturation and differentiation in addition to its role in inflammation. Aim: To study the association between PPAR-γ gene polymorphism and psoriasis vulgaris in Egyptian patients to explore if this polymorphism influenced disease risk or clinical presentation. Methods: Forty-five patients with psoriasis vulgaris and 45 age, sex and body mass index matched healthy volunteers who have no present, past or family history of psoriasis as a control group were enrolled. Selected cases included obese and nonobese participants. Detection of PPAR-γ gene polymorphism was done with restriction fragment length polymorphism polymerase chain reaction. Narrow-band ultraviolet B (NBUVB) was given for every case three times/week for 12 weeks. Results: Homopolymorphism, heteropolymorphism, and Ala allele were significantly associated with cases (P = 0.01, P = 0.01, and P = 0.004, respectively) and increased risk of occurrence of psoriasis by 5.25, 3.65, and 3.37 folds, respectively. Heteropolymorphism was significantly associated with nonobese cases compared to obese ones (P = 0.01). Ala allele was significantly associated with obese cases (P = 0.001) and increased risk of occurrence of psoriasis in obese participants by 1.14 folds. Homopolymorphism, heteropolymorphism, and Ala allele were more prevalent among obese cases without metabolic syndrome (MS) than obese cases with MS but without statistical significance. Percentage of decrease of mean Psoriasis Area and Severity Index score before and after 3 months of treatment with NBUVB was higher in cases with heteropolymorphism with no significant difference between homo- and heteropolymorphism. Conclusion: PPAR-γ gene polymorphism is associated with and increased the risk of psoriasis and its associated obesity in Egyptian patients. It has no role in NBUVB response in those patients. Future large-scale studies on different populations are recommended.
机译:背景:牛皮癣是一种具有多种病因的常见皮肤病,其中遗传因素起主要作用。过氧化物酶体增殖物激活受体(PPAR)-γ在角质形成细胞中表达,已知除影响炎症外,还影响细胞的成熟和分化。目的:研究埃及患者PPAR-γ基因多态性与寻常型牛皮癣之间的关系,以探讨这种多态性是否影响疾病风险或临床表现。方法:纳入45名寻常型银屑病患者,年龄,性别和体重指数均与45名年龄,性别及体重匹配的健康志愿者作为对照组,这些患者均无牛皮癣的现存,既往或家族史。选定的病例包括肥胖和非肥胖参与者。用限制性片段长度多态性聚合酶链反应检测PPAR-γ基因多态性。每种情况下,每周三次给予窄带紫外线B(NBUVB),持续12周。结果:同型多态,异型多态和Ala等位基因与病例显着相关(分别为P = 0.01,P = 0.01和P = 0.004),银屑病发生风险分别增加了5.25、3.65和3.37倍。与肥胖者相比,非肥胖者与异型多态性显着相关(P = 0.01)。 Ala等位基因与肥胖病例显着相关(P = 0.001),并且肥胖参与者中牛皮癣发生的风险增加了1.14倍。在没有代谢综合征(MS)的肥胖病例中,同型多态性,异质多态性和Ala等位基因比具有MS但没有统计学意义的肥胖病例更为普遍。异型多态性病例在使用NBUVB治疗3个月之前和之后,平均银屑病面积和严重性指数得分降低的百分比较高,同型和异型多态性之间无显着差异。结论:PPAR-γ基因多态性与埃及患者牛皮癣及其相关肥胖有关,并增加其风险。在那些患者的NBUVB反应中它没有作用。建议将来对不同人群进行大规模研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号